Potsdam, Germany: biotx.ai, a Potsdam, Germany based genetic analytics start-up today announced the discovery of the direct impacts of cyclin-dependent kinase 6 (CDK6) and neutrophils on patients with severe COVID-19. biotx.ai’s scientists simulated the severe COVID-19 phenotype in genomic data with its proprietary AI prediction platform in order to find gene variants that influence the disease outcome. “Currently investigated immune blockers had only weak signals in our simulation whereas CDK6 inhibitors showed strong causal effects…

Source: RealWire



Source link

By seokuro